{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T09:04:15Z","timestamp":1784019855028,"version":"3.55.0"},"reference-count":352,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is a neurodegenerative disorder that causes progressive loss of cognitive functions like thinking, memory, reasoning, behavioral abilities, and social skills thus affecting the ability of a person to perform normal daily functions independently. There is no definitive cure for this disease, and treatment options available for the management of the disease are not very effective as well. Based on histopathology, AD is characterized by the accumulation of insoluble deposits of amyloid beta (A\u03b2) plaques and neurofibrillary tangles (NFTs). Although several molecular events contribute to the formation of these insoluble deposits, the aberrant post-translational modifications (PTMs) of AD-related proteins (like APP, A\u03b2, tau, and BACE1) are also known to be involved in the onset and progression of this disease. However, early diagnosis of the disease as well as the development of effective therapeutic approaches is impeded by lack of proper clinical biomarkers. In this review, we summarized the current status and clinical relevance of biomarkers from cerebrospinal fluid (CSF), blood and extracellular vesicles involved in onset and progression of AD. Moreover, we highlight the effects of several PTMs on the AD-related proteins, and provide an insight how these modifications impact the structure and function of proteins leading to AD pathology. Finally, for disease-modifying therapeutics, novel approaches, and targets are discussed for the successful treatment and management of AD.<\/jats:p>","DOI":"10.3389\/fnagi.2022.977411","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T07:17:13Z","timestamp":1662535033000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer\u2019s disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Ibtisam","family":"Mumtaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir Owais","family":"Ayaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Sultan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar","family":"Manzoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Azhardin","family":"Ganayee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aadil Qadir","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghulam Hassan","family":"Dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badrah S.","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar M.","family":"Hashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Jamal","family":"Dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulam Md.","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Maqbool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117996","article-title":"Alzheimer\u2019s disease; a review of the pathophysiological basis and therapeutic interventions.","volume":"256","author":"Abeysinghe","year":"2020","journal-title":"Life Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/elps.201500585","article-title":"Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma.","volume":"37","author":"Abou-Abbass","year":"2016","journal-title":"Electrophoresis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"14645","DOI":"10.1523\/JNEUROSCI.1327-13.2013","article-title":"MiR-26b, upregulated in Alzheimer\u2019s disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons.","volume":"33","author":"Absalon","year":"2013","journal-title":"J. Neurosci."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/biom10111569","article-title":"The Role of APP O-glycosylation in Alzheimer\u2019s Disease.","volume":"10","author":"Akasaka-Manya","year":"2020","journal-title":"Biomolecules"},{"key":"B5","article-title":"New hopes for treatment of Alzheimer\u2019s disease.","volume":"10","author":"Akhondzadeh","year":"2017","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1385\/JMN:11:2:151","article-title":"The expression of key oxidative stress-handling genes in different brain regions in Alzheimer\u2019s disease.","volume":"11","author":"Aksenov","year":"1998","journal-title":"J. Mol. Neurosci."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.595532","article-title":"Tau post-translational modifications: Dynamic transformers of tau function, degradation, and aggregation.","volume":"11","author":"Alquezar","year":"2021","journal-title":"Front. Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/ca.980080612","article-title":"An english I\u2019ranslation of Alzheimer\u2019s 1907 paper,\u201cijber eine eigenartige erlranliung der hirnrinde\u201d.","volume":"8","author":"Alzheimer","year":"1995","journal-title":"Clin. Anat."},{"key":"B9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","article-title":"2019 Alzheimer\u2019s disease facts and figures.","volume":"15","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B10","doi-asserted-by":"publisher","first-page":"E9665","DOI":"10.1073\/pnas.1708568114","article-title":"Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer\u2019s disease.","volume":"114","author":"Andrew","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3620001","article-title":"Cross-talk unfolded: MARCKS proteins.","volume":"362","author":"Arbuzova","year":"2002","journal-title":"Biochem. J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","article-title":"The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy.","volume":"40","author":"Ardito","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","article-title":"Depletion of microglia and inhibition of exosome synthesis halt tau propagation.","volume":"18","author":"Asai","year":"2015","journal-title":"Nat. Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1007\/s00259-021-05253-y","article-title":"The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers.","volume":"48","author":"Ashton","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s004010100423","article-title":"Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer\u2019s disease.","volume":"103","author":"Augustinack","year":"2002","journal-title":"Acta Neuropathol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101339","article-title":"Effects of monoclonal antibodies against amyloid-\u03b2 on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer\u2019s disease.","volume":"68","author":"Avgerinos","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"975.","DOI":"10.1016\/j.neuron.2019.12.015","article-title":"Deep multilayer brain proteomics identifies molecular networks in Alzheimer\u2019s disease progression.","volume":"105","author":"Bai","year":"2020","journal-title":"Neuron"},{"key":"B18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.canlet.2009.02.013","article-title":"Isoform-specific histone deacetylase inhibitors: The next step?","volume":"280","author":"Balasubramanian","year":"2009","journal-title":"Cancer Lett."},{"key":"B19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3233\/JAD-2008-15110","article-title":"Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer\u2019s disease.","volume":"15","author":"Baldeiras","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7156928","article-title":"Preliminary data on the interaction between some biometals and oxidative stress status in mild cognitive impairment and Alzheimer\u2019s disease patients.","volume":"2017","author":"Balmu\u015f","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications.","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neurobiolaging.2018.05.033","article-title":"Guanfacine treatment for prefrontal cognitive dysfunction in older participants: A randomized clinical trial.","volume":"70","author":"Barcelos","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"B23","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.nbd.2013.09.018","article-title":"The Janus face of the heme oxygenase\/biliverdin reductase system in Alzheimer disease: It\u2019s time for reconciliation.","volume":"62","author":"Barone","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3233\/JAD-160942","article-title":"Alterations of clock gene RNA expression in brain regions of a triple transgenic model of Alzheimer\u2019s disease.","volume":"59","author":"Bellanti","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0891-5849(94)00244-E","article-title":"Age-and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system.","volume":"19","author":"Benzi","year":"1995","journal-title":"Free Radic. Biol. Med."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9343514","article-title":"Aducanumab therapy to treat Alzheimer\u2019s disease: A narrative review.","volume":"2022","author":"Beshir","year":"2022","journal-title":"Int. J. Alzheimers Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.tins.2008.06.005","article-title":"Neuronal calcium mishandling and the pathogenesis of Alzheimer\u2019s disease.","volume":"31","author":"Bezprozvanny","year":"2008","journal-title":"Trends Neurosci."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2021.07.001","article-title":"CRISPR\/Cas9 gene editing: New hope for Alzheimer\u2019s disease therapeutics.","author":"Bhardwaj","year":"2021","journal-title":"J. Adv. Res."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/7355_2007_015","article-title":"GSK-3 inhibitors for the treatment of Alzheimer\u2019s disease","author":"Bhat","year":"2007","journal-title":"Alzheimer\u2019s disease. topics in medicinal chemistry"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/ma15030804","article-title":"Applications of phyto-nanotechnology for the treatment of neurodegenerative disorders.","volume":"15","author":"Bhattacharya","year":"2022","journal-title":"Materials"},{"key":"B31","doi-asserted-by":"publisher","first-page":"11169","DOI":"10.1523\/JNEUROSCI.4704-12.2013","article-title":"Palmitoylation of amyloid precursor protein regulates amyloidogenic processing in lipid rafts.","volume":"33","author":"Bhattacharyya","year":"2013","journal-title":"J. Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-1-4939-1154-7_3","article-title":"Synthesis, processing, and function of N-glycans in N-glycoproteins.","volume":"9","author":"Bieberich","year":"2014","journal-title":"Adv. Neurobiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/pmic.200300771","article-title":"Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence.","volume":"4","author":"Blom","year":"2004","journal-title":"Proteomics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.trci.2019.01.001","article-title":"Plasma exchange for Alzheimer\u2019s disease management by albumin replacement (AMBAR) trial: Study design and progress.","volume":"5","author":"Boada","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1007\/s00259-020-05120-2","article-title":"The strategic biomarker roadmap for the validation of Alzheimer\u2019s diagnostic biomarkers: Methodological update.","volume":"48","author":"Boccardi","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.17578","article-title":"The amyloid-beta forming tripeptide cleavage mechanism of \u03b3-secretase.","volume":"5","author":"Bolduc","year":"2016","journal-title":"Elife"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00595","article-title":"Direct crosstalk between O-GlcNAcylation and phosphorylation of tau protein investigated by NMR spectroscopy.","volume":"9","author":"Bourr\u00e9","year":"2018","journal-title":"Front. Endocrinol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1096\/fasebj.13.10.1145","article-title":"Vitamin E: Function and metabolism.","volume":"13","author":"Brigelius-Floh\u00e9","year":"1999","journal-title":"FASEB J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1158\/0008-5472.CAN-13-2650","article-title":"Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1.","volume":"74","author":"Bronisz","year":"2014","journal-title":"Cancer Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer\u2019s disease: Pathways, pathogenesis and therapy.","volume":"10","author":"Bu","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.14283\/jpad.2018.18","article-title":"Development of Azeliragon, an oral small molecule antagonist of the receptor for advanced glycation endproducts, for the potential slowing of loss of cognition in mild Alzheimer\u2019s disease.","volume":"5","author":"Burstein","year":"2018","journal-title":"J. Prev. Alzheimers Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"15277","DOI":"10.1074\/jbc.M117.794602","article-title":"An acetylation\u2013phosphorylation switch that regulates tau aggregation propensity and function.","volume":"292","author":"Carlomagno","year":"2017","journal-title":"J. Biol. Chem."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2020.111209","article-title":"Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer\u2019s disease.","volume":"186","author":"Chatterjee","year":"2020","journal-title":"Mech. Ageing Dev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"10698","DOI":"10.1523\/JNEUROSCI.5772-12.2013","article-title":"A novel activator of CBP\/p300 acetyltransferases promotes neurogenesis and extends memory duration in adult mice.","volume":"33","author":"Chatterjee","year":"2013","journal-title":"J. Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: Structure, biology and structure-based therapeutic development.","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1126\/science.1062374","article-title":"Duration of nuclear NF-\u03baB action regulated by reversible acetylation.","volume":"293","author":"Chen","year":"2001","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jss.2015.02.070","article-title":"Selective histone deacetylase 6 inhibition prolongs survival in a lethal two-hit model.","volume":"197","author":"Cheng","year":"2015","journal-title":"J. Surg. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.phrs.2016.06.008","article-title":"Palmitoylation in Alzheimer? s disease and other neurodegenerative diseases.","volume":"111","author":"Cho","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.2174\/092986707780830989","article-title":"The road to advanced glycation end products: A mechanistic perspective.","volume":"14","author":"Cho","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s10571-017-0574-1","article-title":"Tau proteins and tauopathies in Alzheimer\u2019s disease.","volume":"38","author":"Chong","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26164998","article-title":"Curcumin nanoparticles as promising therapeutic agents for drug targets.","volume":"26","author":"Chopra","year":"2021","journal-title":"Molecules"},{"key":"B53","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.bbrc.2015.10.037","article-title":"Threonine 576 residue of amyloid-\u03b2 precursor protein regulates its trafficking and processing.","volume":"467","author":"Chun","year":"","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B54","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3233\/JAD-140096","article-title":"O-GlcNAcylation promotes non-amyloidogenic processing of amyloid-\u03b2 protein precursor via inhibition of endocytosis from the plasma membrane.","volume":"44","author":"Chun","year":"","journal-title":"J. Alzheimers Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrd2896","article-title":"Alzheimer\u2019s disease: Strategies for disease modification.","volume":"9","author":"Citron","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-021-00814-7","article-title":"An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer\u2019s disease.","volume":"13","author":"Clark","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"B57","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/glycob\/6.6.635","article-title":"A family of UDP-GalNAc: Polypeptide N-acetylgalactosaminyl-transferases control the initiation of mucin-type O-linked glycosylation.","volume":"6","author":"Clausen","year":"1996","journal-title":"Glycobiology"},{"key":"B58","author":"Cooper","year":"2020","journal-title":"Lumateperone"},{"key":"B59","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families.","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/ph14090930","article-title":"Antidepressants in Alzheimer\u2019s disease: A focus on the role of mirtazapine.","volume":"14","author":"Correia","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3233\/JAD-161256","article-title":"Effects of regular and long-acting insulin on cognition and Alzheimer\u2019s disease biomarkers: A pilot clinical trial.","volume":"57","author":"Craft","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0896-6273(03)00627-5","article-title":"Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles.","volume":"40","author":"Cruz","year":"2003","journal-title":"Neuron"},{"key":"B63","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.trci.2018.03.009","article-title":"Alzheimer\u2019s disease drug development pipeline: 2018.","volume":"4","author":"Cummings","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12050","article-title":"Alzheimer\u2019s disease drug development pipeline: 2020.","volume":"6","author":"Cummings","year":"2020","journal-title":"Alzheimers Dement."},{"key":"B65","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.trci.2019.05.008","article-title":"Alzheimer\u2019s disease drug development pipeline: 2019.","volume":"5","author":"Cummings","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/jpm10030116","article-title":"Significance of blood and cerebrospinal fluid biomarkers for Alzheimer\u2019s disease: Sensitivity, specificity and potential for clinical use.","volume":"10","author":"d\u2019Abramo","year":"2020","journal-title":"J. Pers. Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.neuron.2013.05.035","article-title":"Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway.","volume":"79","author":"Das","year":"2013","journal-title":"Neuron"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.jalz.2015.05.012","article-title":"C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer\u2019s disease.","volume":"11","author":"De Vos","year":"2015","journal-title":"Alzheimers Dement."},{"key":"B69","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0022-510X(96)00203-1","article-title":"Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer\u2019s disease: Possible relation to oxidative stress.","volume":"143","author":"Deibel","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3233\/JAD-140033","article-title":"PSEN1 and PSEN2 gene expression in Alzheimer\u2019s disease brain: A new approach.","volume":"42","author":"Delabio","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nsmb.1842","article-title":"Post-translational modifications in signal integration.","volume":"17","author":"Deribe","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"9080","DOI":"10.1073\/pnas.1708448114","article-title":"Identification of the Tau phosphorylation pattern that drives its aggregation.","volume":"114","author":"Despres","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B73","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.94.15_supplement.4098","article-title":"COR388 for the treatment of Alzheimer\u2019s disease (4098).","volume":"94","author":"Detke","year":"2020","journal-title":"Neurology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/advances\/nmaa180","article-title":"The efficacy of ketogenic therapies in the clinical management of people with neurodegenerative disease: A systematic review.","volume":"12","author":"Dewsbury","year":"2021","journal-title":"Adv. Nutr."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1016\/j.neurobiolaging.2014.02.011","article-title":"Sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer\u2019s disease with plaques and tangles.","volume":"35","author":"Di Meco","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.6.3.13","article-title":"CRISPR-cas genome surgery in ophthalmology.","volume":"6","author":"DiCarlo","year":"2017","journal-title":"Transl. Vis. Sci. Technol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s11064-018-2641-5","article-title":"Exosomes isolated from human umbilical cord mesenchymal stem cells alleviate neuroinflammation and reduce amyloid-beta deposition by modulating microglial activation in Alzheimer\u2019s disease.","volume":"43","author":"Ding","year":"2018","journal-title":"Neurochem. Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.neurobiolaging.2014.02.012","article-title":"Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer\u2019s disease.","volume":"35","author":"Dinkins","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"B79","doi-asserted-by":"publisher","first-page":"9919","DOI":"10.1074\/jbc.M510127200","article-title":"Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and \u03b1-synuclein.","volume":"281","author":"Dorval","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B80","doi-asserted-by":"publisher","first-page":"12658","DOI":"10.1021\/ja3039486","article-title":"Deamidation accelerates amyloid formation and alters amylin fiber structure.","volume":"134","author":"Dunkelberger","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"B81","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1083\/jcb.143.3.777","article-title":"Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: Implications for Alzheimer\u2019s disease.","volume":"143","author":"Ebneth","year":"1998","journal-title":"J. Cell Biol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate Alzheimer\u2019s disease.","volume":"378","author":"Egan","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"20007","DOI":"10.1021\/acs.jpcc.7b05169","article-title":"Gold nanoparticles as a probe for amyloid-\u03b2 oligomer and amyloid formation.","volume":"121","author":"Elbassal","year":"2017","journal-title":"J. Phys. Chem. C"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2011.00032","article-title":"GSK-3 inhibitors: Preclinical and clinical focus on CNS.","volume":"4","author":"Eldar-Finkelman","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/msj.20159","article-title":"Transgenic mouse models of Alzheimer\u2019s disease.","volume":"77","author":"Elder","year":"2010","journal-title":"Mt. Sinai. J. Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2217\/nmt-2021-0019","article-title":"Masitinib for the treatment of Alzheimer\u2019s disease.","volume":"11","author":"Ettcheto","year":"2021","journal-title":"Neurodegener. Dis. Manag."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.biocel.2010.08.017","article-title":"BACE: Therapeutic target and potential biomarker for Alzheimer\u2019s disease.","volume":"42","author":"Evin","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-019-03545-4","article-title":"Exosomes: Cell-created drug delivery systems.","volume":"459","author":"Familtseva","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-0688-5","article-title":"The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer\u2019s disease model.","volume":"9","author":"Fan","year":"2018","journal-title":"Cell Death Dis."},{"key":"B90","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2174\/1389200222666210525123416","article-title":"New horizons in the treatment of neurological disorders with tailorable gold nanoparticles.","volume":"22","author":"Farheen, Khan","year":"2021","journal-title":"Curr. Drug Metab."},{"key":"B91","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid \u03b2-protein, and the \u03b2-amyloid precursor protein intracellular domain in vivo.","volume":"100","author":"Farris","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B92","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s12017-013-8266-6","article-title":"SUMO: A (oxidative) stressed protein.","volume":"15","author":"Feligioni","year":"2013","journal-title":"Neuromolecular Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3934\/molsci.2015.4.382","article-title":"SUMO modulation of protein aggregation and degradation.","volume":"2","author":"Feligioni","year":"2015","journal-title":"AIMS Mol. Sci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1042\/bj3090041","article-title":"Modulation of the phosphorylation state of tau in situ: The roles of calcium and cyclic AMP.","volume":"309","author":"Fleming","year":"1995","journal-title":"Biochem. J."},{"key":"B95","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1586\/14737175.2015.1045419","article-title":"Masitinib for the treatment of mild to moderate Alzheimer\u2019s disease.","volume":"15","author":"Folch","year":"2015","journal-title":"Expert Rev. Neurother."},{"key":"B96","doi-asserted-by":"publisher","first-page":"8913","DOI":"10.1073\/pnas.1207022109","article-title":"Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer\u2019s disease.","volume":"109","author":"Frieden","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201801362","article-title":"Overcoming the blood\u2013brain barrier: The role of nanomaterials in treating neurological diseases.","volume":"30","author":"Furtado","year":"2018","journal-title":"Adv. Mater."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075091","article-title":"Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.","volume":"8","author":"Gaiottino","year":"2013","journal-title":"PLoS One"},{"key":"B99","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00415-011-6145-3","article-title":"Progress in Alzheimer\u2019s disease.","volume":"259","author":"Galimberti","year":"2012","journal-title":"J. Neurol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/13543784.2017.1265504","article-title":"Pioglitazone for the treatment of Alzheimer\u2019s disease.","volume":"26","author":"Galimberti","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B101","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jacbts.2018.11.004","article-title":"Therapeutic genome editing in cardiovascular diseases.","volume":"4","author":"German","year":"2019","journal-title":"JACC: Basic Transl. Sci."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S105769","article-title":"Genes associated with Alzheimer\u2019s disease: An overview and current status.","volume":"11","author":"Giri","year":"2016","journal-title":"Clin. Interv. Aging"},{"key":"B103","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","article-title":"Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer\u2019s disease.","volume":"3","author":"Goedert","year":"1989","journal-title":"Neuron"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1111\/j.1474-9726.2010.00632.x","article-title":"SCFFbx2-E3-ligase-mediated degradation of BACE1 attenuates Alzheimer\u2019s disease amyloidosis and improves synaptic function.","volume":"9","author":"Gong","year":"2010","journal-title":"Aging Cell"},{"key":"B105","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-3-030-38266-7_6","article-title":"Resistance to the proteasome inhibitors: Lessons from multiple myeloma and mantle cell lymphoma.","volume":"1233","author":"Gonzalez-Santamarta","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"11131","DOI":"10.1021\/acsomega.9b03497","article-title":"Amyloid-\u03b2-derived peptidomimetics inhibits tau aggregation.","volume":"6","author":"Gorantla","year":"2021","journal-title":"ACS Omega."},{"key":"B107","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s100480050011","article-title":"Rediscovery of the case described by alois Alzheimer in 1911: Historical, histological and molecular genetic analysis.","volume":"1","author":"Graeber","year":"1997","journal-title":"Neurogenetics"},{"key":"B108","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10849","article-title":"An epigenetic blockade of cognitive functions in the neurodegenerating brain.","volume":"483","author":"Gr\u00e4ff","year":"2012","journal-title":"Nature"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-54557-5","article-title":"The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer\u2019s disease in rodents.","volume":"9","author":"Griebel","year":"2019","journal-title":"Sci. Rep."},{"key":"B110","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature07925","article-title":"HDAC2 negatively regulates memory formation and synaptic plasticity.","volume":"459","author":"Guan","year":"2009","journal-title":"Nature"},{"key":"B111","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/00001756-199612200-00074","article-title":"Alzheimer\u2019s PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid \u03b2-peptide.","volume":"8","author":"Guo","year":"1996","journal-title":"Neuroreport"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1212\/WNL.0b013e318211c352","article-title":"Plasma apolipoprotein E and Alzheimer disease risk: The AIBL study of aging.","volume":"76","author":"Gupta","year":"2011","journal-title":"Neurology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-020-00686-3","article-title":"\u03b2-Secretase1 biological markers for Alzheimer\u2019s disease: State-of-art of validation and qualification.","volume":"12","author":"Hampel","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"B114","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: Mapping the road to the clinic.","volume":"14","author":"Hampel","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1586\/14737175.2015.995637","article-title":"Advances in the therapy of Alzheimer\u2019s disease: Targeting amyloid beta and tau and perspectives for the future.","volume":"15","author":"Hampel","year":"2015","journal-title":"Expert Rev. Neurother."},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021643","article-title":"Metabolomics in early Alzheimer\u2019s disease: Identification of altered plasma sphingolipidome using shotgun lipidomics.","volume":"6","author":"Han","year":"2011","journal-title":"PLoS One"},{"key":"B117","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","article-title":"Tau phosphorylation: The therapeutic challenge for neurodegenerative disease.","volume":"15","author":"Hanger","year":"2009","journal-title":"Trends Mol. Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"23645","DOI":"10.1074\/jbc.M703269200","article-title":"Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis.","volume":"282","author":"Hanger","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B119","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer\u2019s disease.","volume":"217","author":"Hansen","year":"2018","journal-title":"J. Cell Biol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"26224","DOI":"10.1073\/pnas.1912954116","article-title":"Alzheimer\u2019s disease: A clinical perspective and future nonhuman primate research opportunities.","volume":"116","author":"Haque","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B121","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics.","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.625348","article-title":"Implications of glycosylation in Alzheimer\u2019s disease.","volume":"14","author":"Haukedal","year":"2021","journal-title":"Front. Neurosci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jalz.2013.01.013","article-title":"The future of blood-based biomarkers for Alzheimer\u2019s disease.","volume":"10","author":"Henriksen","year":"2014","journal-title":"Alzheimers Dement."},{"key":"B124","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/BF01067395","article-title":"Pedigrees of 30 families with Alzheimer disease: Associations with defective organization of microfilaments and microtubules.","volume":"8","author":"Heston","year":"1978","journal-title":"Behav. Genet."},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz9360","article-title":"Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer\u2019s disease.","volume":"6","author":"Higginbotham","year":"2020","journal-title":"Sci. Adv."},{"key":"B126","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of solanezumab for mild dementia due to Alzheimer\u2019s disease.","volume":"378","author":"Honig","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B127","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/B978-0-12-800105-9.00034-2","author":"Hooli","year":"2016","journal-title":"The genetic basis of Alzheimer\u2019s disease: Findings from genome-wide studies. Genomics, circuits, and pathways in clinical neuropsychiatry."},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.336","article-title":"Emerging roles of extracellular vesicles in neurodegenerative disorders: Focus on HIV-associated neurological complications.","volume":"7","author":"Hu","year":"2016","journal-title":"Cell Death Dis."},{"key":"B129","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.nbd.2008.10.007","article-title":"GSK3 inhibitors show benefits in an Alzheimer\u2019s disease (AD) model of neurodegeneration but adverse effects in control animals.","volume":"33","author":"Hu","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-019-0609-7","article-title":"Clinical trials of new drugs for Alzheimer disease.","volume":"27","author":"Huang","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"B131","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.tem.2015.09.013","article-title":"Protein phosphorylation: A major switch mechanism for metabolic regulation.","volume":"26","author":"Humphrey","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-017-0355-7","article-title":"Drug candidates in clinical trials for Alzheimer\u2019s disease.","volume":"24","author":"Hung","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"B133","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2019.10.014","article-title":"Brain and blood metabolome for Alzheimer\u2019s dementia: Findings from a targeted metabolomics analysis.","volume":"86","author":"Huo","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.630502","article-title":"APOE and Alzheimer\u2019s disease: From lipid transport to physiopathology and therapeutics.","volume":"15","author":"Husain","year":"2021","journal-title":"Front. Neurosci."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3233\/JAD-200049","article-title":"Drug repositioning for Alzheimer\u2019s disease: Finding hidden clues in old drugs.","volume":"74","author":"Ihara","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"B136","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","article-title":"Tau and neurodegenerative disease: The story so far.","volume":"12","author":"Iqbal","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.bbamem.2016.02.011","article-title":"Exosomes and other extracellular vesicles in neural cells and neurodegenerative diseases.","volume":"1858","author":"Janas","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B138","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1515\/almed-2020-0090","article-title":"Biomarkers in Alzheimer\u2019s disease.","volume":"2","author":"Janeiro","year":"2021","journal-title":"Adv. Lab. Med. Av. En Med. Lab."},{"key":"B139","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/acn3.266","article-title":"Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer\u2019s disease.","volume":"3","author":"Janelidze","year":"","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep26801","article-title":"Plasma \u03b2-amyloid in Alzheimer\u2019s disease and vascular disease.","volume":"6","author":"Janelidze","year":"","journal-title":"Sci. Rep."},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3390\/nano10040690","article-title":"Gold nanoparticles mediate improved detection of \u03b2-amyloid aggregates by fluorescence.","volume":"10","author":"Jara-Guajardo","year":"2020","journal-title":"Nanomaterials"},{"key":"B142","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.molcel.2012.01.011","article-title":"OTUB1 co-opts Lys48-linked ubiquitin recognition to suppress E2 enzyme function.","volume":"45","author":"Juang","year":"2012","journal-title":"Mol. Cell"},{"key":"B143","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1124\/jpet.105.090266","article-title":"Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob\/ob mice: Molecular characterization in liver and muscle.","volume":"316","author":"Kaidanovich-Beilin","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B144","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.biopsych.2004.01.008","article-title":"Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on \u03b2-catenin in mouse hippocampus.","volume":"55","author":"Kaidanovich-Beilin","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00025","article-title":"Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer\u2019s disease.","volume":"12","author":"Kametani","year":"2018","journal-title":"Front. Neurosci."},{"key":"B146","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/j.1467-9280.2009.02402.x","article-title":"The wick in the candle of learning: Epistemic curiosity activates reward circuitry and enhances memory.","volume":"20","author":"Kang","year":"2009","journal-title":"Psychol. Sci."},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118165","article-title":"CRISPR\/Cas9 novel therapeutic road for the treatment of neurodegenerative diseases.","volume":"259","author":"Karimian","year":"2020","journal-title":"Life Sci."},{"key":"B148","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/10717544.2018.1428243","article-title":"Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer\u2019s disease.","volume":"25","author":"Karthivashan","year":"2018","journal-title":"Drug Deliv."},{"key":"B149","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1523\/JNEUROSCI.18-12-04439.1998","article-title":"Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production.","volume":"18","author":"Keller","year":"1998","journal-title":"J. Neurosci."},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.5812\/ijpbs.108390","article-title":"A comparison of methylphenidate (MPH) and combined methylphenidate with crocus sativus (Saffron) in the treatment of children and adolescents with ADHD: A randomized, double-blind, parallel-group, clinical trial. Iran.","volume":"15","author":"Khaksarian","year":"2021","journal-title":"J. Psychiatry Behav. Sci."},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.630055","article-title":"Nanomedicine: A Promising way to manage Alzheimer\u2019s disease.","volume":"9","author":"Khan","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.324842","article-title":"Deuterated dextromethorphan\/quinidine for agitation in Alzheimer\u2019s disease.","volume":"17","author":"Khoury","year":"2022","journal-title":"Neural Regen. Res."},{"key":"B153","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1080\/14656566.2021.1882995","article-title":"AVP-786 as a promising treatment option for Alzheimer\u2019s disease including agitation.","volume":"22","author":"Khoury","year":"2021","journal-title":"Expert Opin. Pharmacother."},{"key":"B154","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neurobiolaging.2012.03.001","article-title":"O-linked \u03b2-N-acetylglucosaminidase inhibitor attenuates \u03b2-amyloid plaque and rescues memory impairment.","volume":"34","author":"Kim","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"B155","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer\u2019s disease.","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"B156","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/jb\/mvq044","article-title":"Regulatory mechanisms involved in the control of ubiquitin homeostasis.","volume":"147","author":"Kimura","year":"2010","journal-title":"J. Biochem."},{"key":"B157","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1016\/j.bbagen.2017.04.012","article-title":"N-glycan and Alzheimer\u2019s disease.","volume":"1861","author":"Kizuka","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"B158","doi-asserted-by":"publisher","first-page":"175","DOI":"10.15252\/emmm.201404438","article-title":"An aberrant sugar modification of BACE 1 blocks its lysosomal targeting in A lzheimer\u2019s disease.","volume":"7","author":"Kizuka","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-019-0559-z","article-title":"Gantenerumab reduces amyloid-\u03b2 plaques in patients with prodromal to moderate Alzheimer\u2019s disease: A PET substudy interim analysis.","volume":"11","author":"Klein","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"B160","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.pnpbp.2017.05.007","article-title":"Molecular imaging of neuroinflammation in Alzheimer\u2019s disease and mild cognitive impairment.","volume":"80","author":"Knezevic","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B161","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0006-8993(99)01415-8","article-title":"An immunochemical study on tau glycation in paired helical filaments.","volume":"830","author":"Ko","year":"1999","journal-title":"Brain Res."},{"key":"B162","doi-asserted-by":"publisher","first-page":"6984","DOI":"10.1074\/jbc.M609521200","article-title":"Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on tau aggregation and filament formation.","volume":"282","author":"Kuhla","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B163","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.neuron.2005.09.023","article-title":"Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum.","volume":"48","author":"Kumar","year":"2005","journal-title":"Neuron"},{"key":"B164","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H","article-title":"Roles of histone acetyltransferases and deacetylases in gene regulation.","volume":"20","author":"Kuo","year":"1998","journal-title":"Bioessays"},{"key":"B165","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.tibs.2017.04.004","article-title":"Dynamic protein acylation: New substrates, mechanisms, and drug targets.","volume":"42","author":"Lanyon-Hogg","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1017\/S1461145711000459","article-title":"Identification of a blood-based biomarker panel for classification of Alzheimer\u2019s disease.","volume":"14","author":"Laske","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1002\/emmm.201201974","article-title":"Alteration of the micro RNA network during the progression of Alzheimer\u2019s disease.","volume":"5","author":"Lau","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002660","article-title":"Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.","volume":"15","author":"Lawlor","year":"2018","journal-title":"PLoS Med."},{"key":"B169","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1523\/JNEUROSCI.4162-03.2004","article-title":"Phosphorylation of tau by fyn: Implications for Alzheimer\u2019s disease.","volume":"24","author":"Lee","year":"2004","journal-title":"J. Neurosci."},{"key":"B170","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0304-4165(02)00477-4","article-title":"Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins\u2014a role in nuclear localization.","volume":"1619","author":"Lefebvre","year":"2003","journal-title":"Biochim. Biophys. Acta."},{"key":"B171","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.1046\/j.1432-1327.2000.01673.x","article-title":"Paullones are potent inhibitors of glycogen synthase kinase-3\u03b2 and cyclin-dependent kinase 5\/p25.","volume":"267","author":"Leost","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"B172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-018-0404-9","article-title":"Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer\u2019s disease.","volume":"10","author":"Lewczuk","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0396-3","article-title":"Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer\u2019s disease.","volume":"12","author":"Li","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2020.0329","article-title":"Roles of the MYST family in the pathogenesis of Alzheimer\u2019s disease via histone or non-histone acetylation.","volume":"12","author":"Li","year":"2021","journal-title":"Aging Dis."},{"key":"B175","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1021\/acsbiomaterials.9b00086","article-title":"Improving sensitivity and specificity of amyloid-\u03b2 peptides and tau protein detection with antibiofouling magnetic nanoparticles for liquid biopsy of Alzheimer\u2019s disease.","volume":"5","author":"Li","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"B176","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1073\/pnas.0235361100","article-title":"Positive and negative regulation of APP amyloidogenesis by sumoylation.","volume":"100","author":"Li","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep26509","article-title":"SUMO5, a novel poly-SUMO isoform, regulates PML nuclear bodies.","volume":"6","author":"Liang","year":"2016","journal-title":"Sci. Rep."},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00571","article-title":"Association of transfusion with risks of dementia or Alzheimer\u2019s disease: A population-based cohort study.","volume":"10","author":"Lin","year":"2019","journal-title":"Front. Psychiatry"},{"key":"B179","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.3892\/mmr.2014.2484","article-title":"MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer\u2019s disease.","volume":"10","author":"Liu","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1111\/j.1460-9568.2005.04391.x","article-title":"Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation.","volume":"22","author":"Liu","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"B181","doi-asserted-by":"publisher","first-page":"10804","DOI":"10.1073\/pnas.0400348101","article-title":"O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer\u2019s disease.","volume":"101","author":"Liu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12157","article-title":"Pharmacological treatment trials of agitation in Alzheimer\u2019s disease: A systematic review of clinicaltrials. Gov registered trials.","volume":"7","author":"Liu","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12646","article-title":"Identification of the A\u03b237\/42 peptide ratio in CSF as an improved A\u03b2 biomarker for Alzheimer\u2019s disease.","author":"Liu","year":"2022","journal-title":"Alzheimers Dement."},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.2174\/9781681085609118070005","volume":"26","author":"Liu","year":"2018","journal-title":"Recent advances in Alzheimer\u2019s drug discovery research"},{"key":"B185","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1046\/j.1471-4159.1999.0720771.x","article-title":"Increased DNA oxidation and decreased levels of repair products in Alzheimer\u2019s disease ventricular CSF.","volume":"72","author":"Lovell","year":"1999","journal-title":"J. Neurochem."},{"key":"B186","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/13543784.2022.2095261","article-title":"ALZT-OP1: An experimental combination regimen for the treatment of Alzheimer\u2019s disease.","volume":"31","author":"Lozupone","year":"2022","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00226","article-title":"Histone acetylation modifiers in the pathogenesis of Alzheimer\u2019s disease.","volume":"9","author":"Lu","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22062806","article-title":"Inhibitors of cyclin-dependent kinases: Types and their mechanism of action.","volume":"22","author":"\u0141ukasik","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B189","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3233\/JAD-2007-12410","article-title":"Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer\u2019s disease 1.","volume":"12","author":"Luna-Munoz","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"B190","doi-asserted-by":"publisher","first-page":"16586","DOI":"10.1073\/pnas.1417548111","article-title":"SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination.","volume":"111","author":"Luo","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B191","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1021\/jz501457f","article-title":"Structural insight into tau protein\u2019s paradox of intrinsically disordered behavior, self-acetylation activity, and aggregation.","volume":"5","author":"Luo","year":"2014","journal-title":"J. Phys. Chem. Lett."},{"key":"B192","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1172\/JCI64516","article-title":"Inhibition of GSK3\u03b2-mediated BACE1 expression reduces Alzheimer-associated phenotypes.","volume":"123","author":"Ly","year":"2012","journal-title":"J. Clin. Investig."},{"key":"B193","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neulet.2017.09.043","article-title":"MicroRNA-125b promotes neurons cell apoptosis and Tau phosphorylation in Alzheimer\u2019s disease.","volume":"661","author":"Ma","year":"2017","journal-title":"Neurosci. Lett."},{"key":"B194","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s40142-020-00190-y","article-title":"Exploring beyond the DNA sequence: A review of epigenomic studies of DNA and histone modifications in dementia.","volume":"8","author":"MacBean","year":"2020","journal-title":"Curr. Genet. Med. Rep."},{"key":"B195","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12031-016-0839-z","article-title":"The complex role of apolipoprotein E in Alzheimer\u2019s disease: An overview and update.","volume":"60","author":"Mahoney-Sanchez","year":"2016","journal-title":"J. Mol. Neurosci."},{"key":"B196","first-page":"573","article-title":"The heme oxygenase system and its functions in the brain.","volume":"46","author":"Maines","year":"2000","journal-title":"Cell. Mol. Biol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep40263","article-title":"Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer\u2019s disease.","volume":"7","author":"Majbour","year":"2017","journal-title":"Sci. Rep."},{"key":"B198","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3233\/JAD-2010-091450","article-title":"High plasma levels of vitamin E forms and reduced Alzheimer\u2019s disease risk in advanced age.","volume":"20","author":"Mangialasche","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"B199","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s11064-015-1681-3","article-title":"Battling Alzheimer\u2019s disease: Targeting SUMOylation-mediated pathways.","volume":"41","author":"Martins","year":"2016","journal-title":"Neurochem. Res."},{"key":"B200","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/s41593-018-0253-7","article-title":"A histone acetylome-wide association study of Alzheimer\u2019s disease identifies disease-associated H3K27ac differences in the entorhinal cortex.","volume":"21","author":"Marzi","year":"2018","journal-title":"Nat. Neurosci."},{"key":"B201","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease.","volume":"74","author":"Mattsson","year":"2017","journal-title":"JAMA Neurol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"e388","DOI":"10.1212\/WNL.0000000000004887","article-title":"Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease.","volume":"90","author":"Mattsson","year":"2018","journal-title":"Neurology."},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006239","article-title":"Epidemiology of Alzheimer disease.","volume":"2","author":"Mayeux","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.190147","article-title":"Cellular functions and molecular mechanisms of non-lysine ubiquitination.","volume":"9","author":"McClellan","year":"2019","journal-title":"Open Biol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1006\/bbrc.1997.7409","article-title":"The role of calcium in the regulation of apoptosis.","volume":"239","author":"McConkey","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B206","doi-asserted-by":"publisher","first-page":"5394","DOI":"10.1523\/JNEUROSCI.5047-06.2007","article-title":"Connecting TNF-\u03b1 signaling pathways to iNOS expression in a mouse model of Alzheimer\u2019s disease: Relevance for the behavioral and synaptic deficits induced by amyloid \u03b2 protein.","volume":"27","author":"Medeiros","year":"2007","journal-title":"J. Neurosci."},{"key":"B207","author":"Mersfelder","year":"2008","journal-title":"Structural and functional characterization of yeast histone acetyltransferase-1."},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00042","article-title":"HDAC4 as a potential therapeutic target in neurodegenerative diseases: A summary of recent achievements.","volume":"9","author":"Mielcarek","year":"2015","journal-title":"Front. Cell Neurosci."},{"key":"B209","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1212\/WNL.0b013e318264e380","article-title":"Serum ceramides increase the risk of Alzheimer disease: The women\u2019s health and aging study II.","volume":"79","author":"Mielke","year":"2012","journal-title":"Neurology"},{"key":"B210","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.3390\/ijms15034671","article-title":"Tau protein modifications and interactions: Their role in function and dysfunction.","volume":"15","author":"Mietelska-Porowska","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"B211","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-019-0672-z","article-title":"Young adult-onset, very slowly progressive cognitive decline with spastic paraparesis in Alzheimer\u2019s disease with cotton wool plaques due to a novel presenilin1 G417S mutation.","volume":"7","author":"Miki","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"B212","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/978-94-007-4525-4_13","article-title":"The role of DNA methylation and histone modifications in transcriptional regulation in humans.","volume":"61","author":"Miller","year":"2013","journal-title":"Epigenetics"},{"key":"B213","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcdb.2019.05.026","article-title":"Advancements in CRISPR\/Cas9 technology\u2014focusing on cancer therapeutics and beyond.","volume":"96","author":"Mirza","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"13194","DOI":"10.1074\/jbc.RA120.012904","article-title":"Amyloid precursor protein 770 is specifically expressed and released from platelets.","volume":"295","author":"Miura","year":"2020","journal-title":"J. Biol. Chem."},{"key":"B215","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1568015053202714","article-title":"Alzheimer\u2019s disease and oxidative stress: The old problem remains unsolved.","volume":"5","author":"Moreira","year":"2005","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"B216","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrm3383","article-title":"Vertebrate protein glycosylation: Diversity, synthesis and function.","volume":"13","author":"Moremen","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B217","doi-asserted-by":"publisher","first-page":"18694","DOI":"10.1074\/jbc.M801322200","article-title":"Promotion of BACE1 mRNA alternative splicing reduces amyloid \u03b2-peptide production.","volume":"283","author":"Mowrer","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B218","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1126\/science.1127085","article-title":"Proteasome-independent functions of ubiquitin in endocytosis and signaling.","volume":"315","author":"Mukhopadhyay","year":"2007","journal-title":"Science"},{"key":"B219","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/14656566.2022.2042514","article-title":"Pharmacotherapeutic combinations for the treatment of Alzheimer\u2019s disease.","volume":"23","author":"Nagata","year":"2022","journal-title":"Expert Opin. Pharmacother."},{"key":"B220","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease.","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194802","article-title":"Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study.","volume":"13","author":"Neergaard","year":"2018","journal-title":"PLoS One"},{"key":"B222","author":"Nesterova","year":"2019","journal-title":"Disease pathways: An atlas of human disease signaling pathways."},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809316","article-title":"The BACE-1 inhibitor CNP 520 for prevention trials in Alzheimer\u2019s disease.","volume":"10","author":"Neumann","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"B224","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1110\/ps.48702","article-title":"Low levels of asparagine deamidation can have a dramatic effect on aggregation of amyloidogenic peptides: Implications for the study of amyloid formation.","volume":"11","author":"Nilsson","year":"2002","journal-title":"Protein Sci."},{"key":"B225","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-020-00614-5","article-title":"Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer\u2019s disease spectrum patients: A randomized, double-blind, placebo-controlled study and a two-period extension study.","volume":"12","author":"Novak","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer\u2019s disease.","volume":"34","author":"O\u2019brien","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"key":"B227","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1001\/archneurol.2010.215","article-title":"A serum protein\u2013based algorithm for the detection of Alzheimer disease.","volume":"67","author":"O\u2019Bryant","year":"2010","journal-title":"Arch. Neurol."},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.3390\/cells8030209","article-title":"Presenilins and \u03b3-secretase in membrane proteostasis.","volume":"8","author":"Oikawa","year":"2019","journal-title":"Cells"},{"key":"B229","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: A systematic review and meta-analysis.","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"B230","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jalz.2017.06.2266","article-title":"Amyloid \u03b2 concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis.","volume":"13","author":"Ovod","year":"2017","journal-title":"Alzheimers Dement."},{"key":"B231","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.1002\/chem.201400079","article-title":"Inhibition of amyloid fibril growth and dissolution of amyloid fibrils by curcumin\u2013gold nanoparticles.","volume":"20","author":"Palmal","year":"2014","journal-title":"Chem. Eur. J."},{"key":"B232","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neulet.2014.04.041","article-title":"The amyloid-\u03b2 degradation pattern in plasma\u2014a possible tool for clinical trials in Alzheimer\u2019s disease.","volume":"573","author":"Pannee","year":"2014","journal-title":"Neurosci. Lett."},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3245935","article-title":"Tau-centric targets and drugs in clinical development for the treatment of Alzheimer\u2019s disease.","volume":"2016","author":"Panza","year":"2016","journal-title":"Biomed Res. Int."},{"key":"B234","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-16361-y","article-title":"HDAC1 modulates OGG1-initiated oxidative DNA damage repair in the aging brain and Alzheimer\u2019s disease.","volume":"11","author":"Pao","year":"2020","journal-title":"Nat. Commun."},{"key":"B235","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3892\/ijmm.2013.1407","article-title":"Selective inhibition of PCAF suppresses microglial-mediated \u03b2-amyloid neurotoxicity.","volume":"32","author":"Park","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"B236","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.2174\/1570159X19666211201094031","article-title":"BACE1: A key regulator in Alzheimer\u2019s disease progression and current development of its inhibitors.","volume":"20","author":"Patel","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"B237","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/j.bbadis.2016.07.005","article-title":"Aberrant protein phosphorylation in Alzheimer disease brain disturbs pro-survival and cell death pathways.","volume":"1862","author":"Perluigi","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B238","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1038\/s41380-022-01518-6","article-title":"A\u03b2 profiles generated by Alzheimer\u2019s disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset.","volume":"27","author":"Petit","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"B239","doi-asserted-by":"publisher","first-page":"13966","DOI":"10.1523\/JNEUROSCI.3637-10.2010","article-title":"Silencing of CDK5 reduces neurofibrillary tangles in transgenic Alzheimer\u2019s mice.","volume":"30","author":"Piedrahita","year":"2010","journal-title":"J. Neurosci."},{"key":"B240","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.arr.2016.01.002","article-title":"Brain atrophy in Alzheimer\u2019s disease and aging.","volume":"30","author":"Pini","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"B241","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/14656566.2017.1307340","article-title":"An update on the advancements in the treatment of agitation in Alzheimer\u2019s disease.","volume":"18","author":"Porsteinsson","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2020.112547","article-title":"Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors enhance procognitive effects of conventional anti-Alzheimer drugs in scopolamine-treated rats.","volume":"385","author":"Potasiewicz","year":"2020","journal-title":"Behav. Brain Res."},{"key":"B243","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3233\/JAD-2010-1317","article-title":"PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3\u03b2.","volume":"19","author":"Qian","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029641","article-title":"Protective effects of a Rhodiola crenulata extract and salidroside on hippocampal neurogenesis against streptozotocin-induced neural injury in the rat.","volume":"7","author":"Qu","year":"2012","journal-title":"PLoS One."},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.26.010330","article-title":"Cell type-specific histone acetylation profiling of Alzheimer\u2019s Disease subjects and integration with genetics.","volume":"10330","author":"Ramamurthy","year":"2020","journal-title":"bioRxiv [Preprint]"},{"key":"B246","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/cbic.201900573","article-title":"Role of post-translational modifications in Alzheimer\u2019s disease.","volume":"21","author":"Ramesh","year":"2020","journal-title":"Chembiochem"},{"key":"B247","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41580-019-0158-7","article-title":"Extracellular vesicles: A new communication paradigm?","volume":"20","author":"Raposo","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B248","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nrm2468","article-title":"Diversity of degradation signals in the ubiquitin\u2013proteasome system.","volume":"9","author":"Ravid","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B249","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","article-title":"Glycosylation in health and disease.","volume":"15","author":"Reily","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"B250","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.plipres.2016.05.002","article-title":"Fatty acylation of proteins: The long and the short of it.","volume":"63","author":"Resh","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/254954","article-title":"Genetics of Alzheimer\u2019s disease.","volume":"2013","author":"Ridge","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"B252","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S0197-4580(03)00031-9","article-title":"Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer\u2019s disease.","volume":"24","author":"Rinaldi","year":"2003","journal-title":"Neurobiol. Aging."},{"key":"B253","doi-asserted-by":"publisher","first-page":"12409","DOI":"10.1073\/pnas.221463198","article-title":"Deamidation of human proteins.","volume":"98","author":"Robinson","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B254","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1016\/S0021-9258(18)53661-9","article-title":"Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer\u2019s disease.","volume":"268","author":"Roher","year":"1993","journal-title":"J. Biol. Chem."},{"key":"B255","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.1093\/emboj\/cdg615","article-title":"Critical loss of CBP\/p300 histone acetylase activity by caspase-6 during neurodegeneration.","volume":"22","author":"Rouaux","year":"2003","journal-title":"EMBO J."},{"key":"B256","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/0891988719874118","article-title":"Agitation, oxidative stress, and cytokines in Alzheimer disease: Biomarker analyses from a clinical trial with nabilone for agitation.","volume":"33","author":"Ruthirakuhan","year":"2020","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"B257","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1016\/j.febslet.2012.05.008","article-title":"The human phosphatase interactome: An intricate family portrait.","volume":"586","author":"Sacco","year":"2012","journal-title":"FEBS Lett."},{"key":"B258","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/s41591-021-01369-8","article-title":"A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer\u2019s disease.","volume":"27","author":"Salloway","year":"2021","journal-title":"Nat. Med."},{"key":"B259","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-018-0424-5","article-title":"Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer\u2019s disease (BLAZE).","volume":"10","author":"Salloway","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"B260","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1074\/jbc.M111.277061","article-title":"Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease.","volume":"287","author":"Saman","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5716409","article-title":"Protein posttranslational modifications: Roles in aging and age-related disease.","volume":"2017","author":"Santos","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B262","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/jnc.15116","article-title":"Quantitative proteomic analysis of the frontal cortex in Alzheimer\u2019s disease.","volume":"156","author":"Sathe","year":"2021","journal-title":"J. Neurochem."},{"key":"B263","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/febs.12590","article-title":"The role of protein glycosylation in Alzheimer disease.","volume":"281","author":"Schedin-Weiss","year":"2014","journal-title":"FEBS J."},{"key":"B264","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41418-020-00706-7","article-title":"Ubiquitin signalling in neurodegeneration: Mechanisms and therapeutic opportunities.","volume":"28","author":"Schmidt","year":"2021","journal-title":"Cell Death Differ."},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0798-4","article-title":"Genome editing for inborn errors of metabolism: Advancing towards the clinic.","volume":"15","author":"Schneller","year":"2017","journal-title":"BMC Med."},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.792227","article-title":"Advances in proteomic and metabolomic profiling of neurodegenerative diseases.","volume":"12","author":"Schumacher-Schuh","year":"2021","journal-title":"Front. Neurol."},{"key":"B267","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.nbd.2009.05.025","article-title":"A novel GSK-3\u03b2 inhibitor reduces Alzheimer\u2019s pathology and rescues neuronal loss in vivo.","volume":"35","author":"Seren\u00f3","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"B268","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/ana.24369","article-title":"APOE\u03b52 is associated with milder clinical and pathological Alzheimer\u2019s disease.","volume":"77","author":"Serrano-Pozo","year":"2015","journal-title":"Ann. Neurol."},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: The histone deacetylase enzymes.","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B270","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease.","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"B271","doi-asserted-by":"publisher","first-page":"45","DOI":"10.14218\/JERP.2021.00030","article-title":"Porphyromonas gingivalis in the pathogenesis of Alzheimer\u2019s disease and its therapeutic target.","volume":"7","author":"Seymour","year":"2021","journal-title":"J Explor Res. Pharmacol."},{"key":"B272","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1146\/annurev.biochem.76.052705.162114","article-title":"Functions of site-specific histone acetylation and deacetylation.","volume":"76","author":"Shahbazian","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"B273","doi-asserted-by":"publisher","first-page":"e2658","DOI":"10.1212\/WNL.0000000000010725","article-title":"Effect of escitalopram dose and treatment duration on CSF A\u03b2 levels in healthy older adults: A controlled clinical trial.","volume":"95","author":"Sheline","year":"2020","journal-title":"Neurology"},{"key":"B274","doi-asserted-by":"publisher","first-page":"8256","DOI":"10.1073\/pnas.0801340105","article-title":"Effect of glycosylation on protein folding: A close look at thermodynamic stabilization.","volume":"105","author":"Shental-Bechor","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101554","article-title":"Roles of clock genes in the pathogenesis of Parkinson\u2019s disease.","volume":"74","author":"Shkodina","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"B276","doi-asserted-by":"publisher","first-page":"10143","DOI":"10.3390\/ijms130810143","article-title":"Epigenetic effects of environmental chemicals bisphenol A and phthalates.","volume":"13","author":"Singh","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"B277","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jalz.2013.10.007","article-title":"Developing novel blood-based biomarkers for Alzheimer\u2019s disease.","volume":"10","author":"Snyder","year":"2014","journal-title":"Alzheimers Dement."},{"key":"B278","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/jnc.15112","article-title":"Diagnostic and therapeutic potential of exosomes in Alzheimer\u2019s disease.","volume":"156","author":"Soares Martins","year":"2021","journal-title":"J. Neurochem."},{"key":"B279","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1001\/archneurol.2012.1070","article-title":"Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease.","volume":"69","author":"Soares","year":"2012","journal-title":"Arch. Neurol."},{"key":"B280","doi-asserted-by":"publisher","first-page":"43R","DOI":"10.1093\/glycob\/12.4.43R","article-title":"Protein glycosylation: Nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds.","volume":"12","author":"Spiro","year":"2002","journal-title":"Glycobiology"},{"key":"B281","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1083\/jcb.145.6.1277","article-title":"A myristoylated calcium-binding protein that preferentially interacts with the Alzheimer\u2019s disease presenilin 2 protein.","volume":"145","author":"Stabler","year":"1999","journal-title":"J. Cell Biol."},{"key":"B282","doi-asserted-by":"publisher","first-page":"29627","DOI":"10.1074\/jbc.R800010200","article-title":"Intramembrane proteolysis by \u03b3-secretase.","volume":"283","author":"Steiner","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B283","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbadis.2004.06.017","article-title":"Tau phosphorylation: Physiological and pathological consequences.","volume":"1739","author":"Stoothoff","year":"2005","journal-title":"Biochim. Biophys. Acta."},{"key":"B284","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1101\/gad.12.5.599","article-title":"Histone acetylation and transcriptional regulatory mechanisms.","volume":"12","author":"Struhl","year":"1998","journal-title":"Genes Dev."},{"key":"B285","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s12264-010-0131-0","article-title":"A possible role of myristoylated alanine-rich C kinase substrate in endocytic pathway of Alzheimer\u2019s disease.","volume":"26","author":"Su","year":"2010","journal-title":"Neurosci. Bull."},{"key":"B286","doi-asserted-by":"publisher","first-page":"466","DOI":"10.15252\/emmm.201506123","article-title":"sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer\u2019s disease and associate with neuronal injury markers.","volume":"8","author":"Su\u00e1rez-Calvet","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"B287","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1074\/jbc.M110.199976","article-title":"Nuclear tau, a key player in neuronal DNA protection.","volume":"286","author":"Sultan","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B288","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-07971-8","article-title":"CRISPR\/Cas9 editing of APP C-terminus attenuates \u03b2-cleavage and promotes \u03b1-cleavage.","volume":"10","author":"Sun","year":"2019","journal-title":"Nat. Commun."},{"key":"B289","doi-asserted-by":"publisher","first-page":"E476","DOI":"10.1073\/pnas.1618657114","article-title":"Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of A\u03b242 and A\u03b240 peptides by \u03b3-secretase.","volume":"114","author":"Sun","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B290","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.trac.2019.04.019","article-title":"Protein post-translational modifications\u2013A challenge for bioelectrochemistry.","volume":"116","author":"Suprun","year":"2019","journal-title":"Trends Anal. Chem."},{"key":"B291","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1021\/bi300478w","article-title":"\u03b3-Synuclein: Seeding of \u03b1-synuclein aggregation and transmission between cells.","volume":"51","author":"Surgucheva","year":"2012","journal-title":"Biochemistry"},{"key":"B292","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cct.2019.02.007","article-title":"Rationale and methods for a multicenter clinical trial assessing exercise and intensive vascular risk reduction in preventing dementia (rrAD Study).","volume":"79","author":"Szabo-Reed","year":"2019","journal-title":"Contemp. Clin. Trials"},{"key":"B293","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.7573\/dic.2021-7-3","article-title":"Aducanumab: Evidence from clinical trial data and controversies.","volume":"10","author":"Tampi","year":"2021","journal-title":"Drugs Context"},{"key":"B294","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/cdd.2016.161","article-title":"Epigenetic regulation of HDAC1 SUMOylation as an endogenous neuroprotection against A \u03b2 toxicity in a mouse model of Alzheimer\u2019s disease.","volume":"24","author":"Tao","year":"2017","journal-title":"Cell Death Differ."},{"key":"B295","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cbpa.2014.10.016","article-title":"Global profiling of protein lipidation using chemical proteomic technologies.","volume":"24","author":"Tate","year":"2015","journal-title":"Curr. Opin. Chem. Biol."},{"key":"B296","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1111\/j.1432-1033.2004.04174.x","article-title":"How mammalian transcriptional repressors work.","volume":"271","author":"Thiel","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"B297","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms5919","article-title":"Global profiling of co-and post-translationally N-myristoylated proteomes in human cells.","volume":"5","author":"Thinon","year":"2014","journal-title":"Nat. Commun."},{"key":"B298","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease.","volume":"57","author":"T\u00f6nnies","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B299","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201701921","article-title":"Drug delivery to the brain across the blood\u2013brain barrier using nanomaterials.","volume":"13","author":"Tsou","year":"2017","journal-title":"Small"},{"key":"B300","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8820406","article-title":"Natural products for neurodegeneration: Regulating neurotrophic signals.","volume":"2021","author":"Uddin","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B301","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/0269881118822161","article-title":"Lithium treatment for unipolar major depressive disorder: Systematic review.","volume":"33","author":"Undurraga","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"B302","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1038\/sj.emboj.7600655","article-title":"PIP2 signaling in lipid domains: A critical re-evaluation.","volume":"24","author":"van Rheenen","year":"2005","journal-title":"EMBO J."},{"key":"B303","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/glycob\/cww086","article-title":"Biological roles of glycans.","volume":"27","author":"Varki","year":"2017","journal-title":"Glycobiology"},{"key":"B304","doi-asserted-by":"publisher","first-page":"12787","DOI":"10.1523\/JNEUROSCI.3657-09.2009","article-title":"The \u03b2-secretase enzyme BACE in health and Alzheimer\u2019s disease: Regulation, cell biology, function, and therapeutic potential.","volume":"29","author":"Vassar","year":"2009","journal-title":"J. Neurosci."},{"key":"B305","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S1474-4422(12)70206-5","article-title":"Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer\u2019s disease (GuidAge): A randomised placebo-controlled trial.","volume":"11","author":"Vellas","year":"2012","journal-title":"Lancet Neurol."},{"key":"B306","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3941","article-title":"Histone exchange, chromatin structure and the regulation of transcription.","volume":"16","author":"Venkatesh","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B307","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.coph.2015.09.011","article-title":"Astroglia dynamics in ageing and Alzheimer\u2019s disease.","volume":"26","author":"Verkhratsky","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"key":"B308","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1074\/jbc.M808920200","article-title":"Alzheimer disease A\u03b2 production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts.","volume":"284","author":"Vetrivel","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B309","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3233\/JAD-170056","article-title":"Chronic verubecestat treatment suppresses amyloid accumulation in advanced aged Tg2576-A\u03b2PP swe mice without inducing microhemorrhage.","volume":"59","author":"Villarreal","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B310","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.nepig.2014.10.002","article-title":"Histone deacetylases (HDACs) and brain function.","volume":"1","author":"Volmar","year":"2015","journal-title":"Neuroepigenetics"},{"key":"B311","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1152\/physiol.00009.2008","article-title":"Presenilins: Members of the \u03b3-secretase quartets, but part-time soloists too.","volume":"23","author":"Wakabayashi","year":"2008","journal-title":"Physiology (Bethesda)"},{"key":"B312","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/jnnp.2003.010611","article-title":"Novel amyloid precursor protein gene missense mutation (D678N) in probable familial Alzheimer\u2019s disease.","volume":"75","author":"Wakutani","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B313","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s12035-021-02617-1","article-title":"Delineation of neuroprotective effects and possible benefits of antioxidantstherapy for the treatment of Alzheimer\u2019s diseases by targeting mitochondrial-derived reactive oxygen species: Bench to bedside.","volume":"59","author":"Walia","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"B314","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.3233\/JAD-2012-129031","article-title":"Abnormal hyperphosphorylation of tau: Sites, regulation, and molecular mechanism of neurofibrillary degeneration.","volume":"33","author":"Wang","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"B315","doi-asserted-by":"publisher","first-page":"606","DOI":"10.2174\/156720512800618026","article-title":"Lys203 and Lys382 are essential for the proteasomal degradation of BACE1.","volume":"9","author":"Wang","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"B316","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-020-00678-3","article-title":"A phase II randomized trial of sodium oligomannate in Alzheimer\u2019s dementia.","volume":"12","author":"Wang","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"B317","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease.","volume":"3","author":"Wang","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"B318","doi-asserted-by":"publisher","first-page":"7162","DOI":"10.1021\/acs.analchem.0c00655","article-title":"27-Plex tandem mass tag mass spectrometry for profiling brain proteome in Alzheimer\u2019s disease.","volume":"92","author":"Wang","year":"2020","journal-title":"Anal. Chem."},{"key":"B319","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0317-5","article-title":"Neuronally derived extracellular vesicles: An emerging tool for understanding Alzheimer\u2019s disease.","volume":"14","author":"Watson","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"B320","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.yexcr.2006.10.028","article-title":"Alterations in immunological and neurological gene expression patterns in Alzheimer\u2019s disease tissues.","volume":"313","author":"Weeraratna","year":"2007","journal-title":"Exp. Cell Res."},{"key":"B321","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1212\/WNL.0000000000002423","article-title":"Increased CSF neurogranin concentration is specific to Alzheimer disease.","volume":"86","author":"Wellington","year":"2016","journal-title":"Neurology"},{"key":"B322","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/jamaneurol.2019.3988","article-title":"Efficacy and safety of lanabecestat for treatment of early and mild Alzheimer disease: The AMARANTH and DAYBREAK-ALZ randomized clinical trials.","volume":"77","author":"Wessels","year":"2020","journal-title":"JAMA Neurol."},{"key":"B323","doi-asserted-by":"publisher","first-page":"19873","DOI":"10.1074\/jbc.M117.818138","article-title":"Disruption of amyloid precursor protein ubiquitination selectively increases amyloid \u03b2 (A\u03b2) 40 levels via presenilin 2-mediated cleavage.","volume":"292","author":"Williamson","year":"2017","journal-title":"J. Biol. Chem."},{"key":"B324","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12154-009-0032-8","article-title":"Protein myristoylation in health and disease.","volume":"3","author":"Wright","year":"2010","journal-title":"J. Chem. Biol."},{"key":"B325","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1111\/jgs.15018","article-title":"The association between the use of zolpidem and the risk of Alzheimer\u2019s disease among older people.","volume":"65","author":"Wu","year":"2017","journal-title":"J. Am. Geriatr. Soc."},{"key":"B326","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.neuron.2015.02.010","article-title":"Presenilin-1 knockin mice reveal loss-of-function mechanism for familial Alzheimer\u2019s disease.","volume":"85","author":"Xia","year":"2015","journal-title":"Neuron"},{"key":"B327","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1155\/2006\/276239","article-title":"Microglia activation in the brain as inflammatory biomarker of Alzheimer\u2019s disease neuropathology and clinical dementia.","volume":"22","author":"Xiang","year":"2006","journal-title":"Dis. Markers"},{"key":"B328","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030479","article-title":"Can we use ginkgo biloba extract to treat Alzheimer\u2019s disease? Lessons from preclinical and clinical studies.","volume":"11","author":"Xie","year":"2022","journal-title":"Cells"},{"key":"B329","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/143269","article-title":"Targeting HDACs: A promising therapy for Alzheimer\u2019s disease.","volume":"2011","author":"Xu","year":"2011","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B330","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1534\/genetics.114.171660","article-title":"Epigenetic control of learning and memory in Drosophila by Tip60 HAT action.","volume":"198","author":"Xu","year":"2014","journal-title":"Genetics"},{"key":"B331","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.33481","article-title":"CRISPR\/Cas9-related technologies in liver diseases: From feasibility to future diversity.","volume":"16","author":"Xu","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"B332","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s12264-012-1272-0","article-title":"Metabolomics: A novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer\u2019s disease.","volume":"28","author":"Xu","year":"2012","journal-title":"Neurosci. Bull."},{"key":"B333","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10787-017-0372-x","article-title":"Vitamin D3 attenuates cognitive deficits and neuroinflammatory responses in ICV-STZ induced sporadic Alzheimer\u2019s disease.","volume":"26","author":"Yamini","year":"2018","journal-title":"Inflammopharmacology"},{"key":"B334","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.freeradbiomed.2012.11.014","article-title":"Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease.","volume":"62","author":"Yan","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"B335","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3233\/JAD-170810","article-title":"Assay of plasma phosphorylated tau protein (threonine 181) and total tau protein in early-stage Alzheimer\u2019s disease.","volume":"61","author":"Yang","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"B336","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2021\/e2348","article-title":"Azeliragon ameliorates Alzheimer\u2019s disease via the Janus tyrosine kinase and signal transducer and activator of transcription signaling pathway.","volume":"76","author":"Yang","year":"2021","journal-title":"Clinics"},{"key":"B337","doi-asserted-by":"publisher","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in Alzheimer disease: An update.","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"B338","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00726-010-0705-1","article-title":"Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody.","volume":"40","author":"Yuzwa","year":"2011","journal-title":"Amino Acids."},{"key":"B339","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2174\/1874467213666200422090135","article-title":"Recent updates in the Alzheimer\u2019s disease etiopathology and possible treatment approaches: A narrative review of current clinical trials.","volume":"13","author":"Zarini-Gakiye","year":"2020","journal-title":"Curr. Mol. Pharmacol."},{"key":"B340","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt163","article-title":"Plasma tau levels in Alzheimer\u2019s disease.","volume":"5","author":"Zetterberg","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"B341","doi-asserted-by":"publisher","first-page":"33067","DOI":"10.1074\/jbc.M212635200","article-title":"Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium: Evidence for autoregulation of GSK-3.","volume":"278","author":"Zhang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B342","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejphar.2007.01.089","article-title":"Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells.","volume":"564","author":"Zhang","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"B343","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1523\/JNEUROSCI.4043-13.2014","article-title":"Omega-3 fatty acids protect the brain against ischemic injury by activating Nrf2 and upregulating heme oxygenase 1.","volume":"34","author":"Zhang","year":"2014","journal-title":"J. Neurosci."},{"key":"B344","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.neubiorev.2015.07.003","article-title":"Association between variant amyloid deposits and motor deficits in FAD-associated presenilin-1 mutations: A systematic review.","volume":"56","author":"Zhang","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B345","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1515\/revneuro-2017-0013","article-title":"The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer\u2019s disease.","volume":"28","author":"Zhang","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"B346","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.bbrc.2008.07.109","article-title":"Sumoylation of amyloid precursor protein negatively regulates A\u03b2 aggregate levels.","volume":"374","author":"Zhang","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B347","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00137","article-title":"Targeting amyloidogenic processing of APP in Alzheimer\u2019s disease.","volume":"13","author":"Zhao","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"B348","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4314\/tjpr.v19i2.29","article-title":"Therapeutic benefit of aripiprazole-olanzapine combination in the treatment of senile Alzheimer\u2019s disease complicated by mental disorders.","volume":"19","author":"Zheng","year":"2020","journal-title":"Trop. J. Pharm. Res."},{"key":"B349","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neurobiolaging.2020.02.020","article-title":"Suvorexant ameliorates cognitive impairments and pathology in APP\/PS1 transgenic mice.","volume":"91","author":"Zhou","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"B350","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00027","article-title":"Relevance of phosphorylation and truncation of tau to the etiopathogenesis of Alzheimer\u2019s disease.","volume":"10","author":"Zhou","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"B351","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc7031","article-title":"Blood-brain barrier\u2013penetrating siRNA nanomedicine for Alzheimer\u2019s disease therapy.","volume":"6","author":"Zhou","year":"2020","journal-title":"Sci. Adv."},{"key":"B352","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1093\/jnen\/59.10.880","article-title":"Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease.","volume":"59","author":"Zhu","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.977411\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T10:35:54Z","timestamp":1727951754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.977411\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":352,"alternative-id":["10.3389\/fnagi.2022.977411"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2022.977411","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"article-number":"977411"}}